LEO Pharma opens new API facility in Ballerup
The company marks its largest single investment ever to enhance production capacity and deliver reliable treatments globally.
See the latest news and media coverage for LEO Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical dermatology pharmaceutical company
leo-pharma.comLast updated
In short: LEO Pharma reported 10% revenue growth in H1 2026, raised its outlook, and expanded its portfolio through key acquisitions and R&D.
The company marks its largest single investment ever to enhance production capacity and deliver reliable treatments globally.
The company highlights portfolio expansion through targeted acquisitions and advanced clinical trials for rare dermatological conditions.
She brings deep pharmaceutical R&D and innovation expertise, having held senior roles at ALK and Novo Nordisk.
The award recognizes its commitment to the EB community and its recent acquisition for gene therapy
With a payment of up to 2.8 billion DKK, Leo Pharma is acquiring a new drug for a rare skin disease. Despite an upward revision of growth outlook, the...
Danish drugmaker LEO Pharma said on Tuesday it had agreed to acquire worldwide rights to drug candidate dersimelagon from ...
The Danish pharmaceutical company's growth in Russia raises, according to European spokesperson Kasper Roug (S), »serious ethical and societal questions«. The company owes an explanation, he believes. Leo Pharma...
LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab ...
Track LEO Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.